Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products

An ultra-performance liquid chromatographic method for simultaneous determination of rosuvastatin and rosuvastatin degradation products was developed and optimized by using fractional factorial experimental design. Optimized method is capable to accurately determine all potential degradation product...

Full description

Bibliographic Details
Main Authors:	Jure Zakrajšek, Katarina Bevc-Černilec, Simona Bohanec, Uroš Urleb
Format:	Article
Language:	English
Published:	Slovenian Chemical Society 2017-12-01
Series:	Acta Chimica Slovenica
Subjects:	Fractional factorial design experimental design UPLC method optimization rosuvastatin
Online Access:	https://journals.matheo.si/index.php/ACSi/article/view/3662

Similar Items

Quality by Design Based Optimization of a High Performance Liquid Chromatography Method for Assay Determination of Low Concentration Preservatives in Complex Nasal Formulations
by: Jure Zakrajšek, et al.
Published: (2015-03-01)

Development and validation of a stability-indicating UPLC method for rosuvastatin and its related impurities in pharmaceutical dosage forms
by: Gosula Venkat Ram Reddy, et al.
Published: (2011-01-01)

Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study
by: Mahmoud M. A. Elsayed, et al.
Published: (2022-08-01)

Rosuvastatin-Induced reversible rhabdomyolysis
by: Sangeeta Pradhan, et al.
Published: (2023-01-01)

Rosuvastatin induced photolocalized purpura
by: Marwa Thabouti, et al.
Published: (2022-09-01)

ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
by: Nadeem Ul Haq, et al.
Published: (2019-12-01)

Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats
by: Neves Valdir A, et al.
Published: (2011-09-01)

The Effect of Rosuvastatin on the Liver Enzyme of NMRI Mouse
by: Atena Nehzati Asl, et al.
Published: (2022-05-01)

Analysis of genetic aspects of therapy with Rosuvastatin
by: Samat Kozhakhmetov, et al.
Published: (2016-06-01)

An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
by: Eman A. Mostafa, et al.
Published: (2023-11-01)

Rosuvastatin as forthcoming antibiotic or as adjuvant additive agent: In vitro novel antibacterial study
by: Hayder M. Al-Kuraishy, et al.
Published: (2018-07-01)

Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
by: Wen Wang, et al.
Published: (2022-04-01)

Chemometric technique for the optimization of chromatographic system: Simultaneous HPLC determination of Rosuvastatin, Telmisartan, Ezetimibe and Atorvastatin used in combined cardiovascular therapy
by: V. Sree Janardhanan, et al.
Published: (2016-11-01)

Wound Healing Efficacy of Rosuvastatin Transethosomal Gel, I Optimal Optimization, Histological and In Vivo Evaluation
by: Randa Mohammed Zaki, et al.
Published: (2022-11-01)

Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin
by: Monica Força Lima, et al.
Published: (2017-07-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
by: Anikin G.S., et al.
Published: (2017-11-01)

Enhancing Pharmacokinetics and Pharmacodynamics of Rosuvastatin Calcium through the Development and Optimization of Fast-Dissolving Films
by: Ibrahim Ashraf, et al.
Published: (2023-11-01)

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects
by: E V Luchinina, et al.
Published: (2017-12-01)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
by: Parson H
Published: (2010-01-01)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe in Pharmaceutical Formulations
by: Mathrusri Annapurna Mukthinuthalapati, et al.
Published: (2014-12-01)

LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS
by: A. N. Meshkov
Published: (2015-12-01)

Role of rosuvastatin in bone metabolism of ovariectomized adult rats
by: Sumaya S. Salih, et al.
Published: (2023-01-01)

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
by: Ji Hoe Heo, et al.
Published: (2016-01-01)

A comparative study of atorvastatin and rosuvastatin on lipid lowering efficacy in hyperlipidemic patients
by: Samia Haque Tonu, et al.
Published: (2018-03-01)

NanoUPLC-QTOF-MS/MS Determination of Major Rosuvastatin Degradation Products Generated by Gamma Radiation in Aqueous Solution
by: Lucija Dončević, et al.
Published: (2021-11-01)

The impact of rosuvastatin on inflammatory markers in L-NAME induced hypertensive rats
by: Kawa F. Dizaye, et al.
Published: (2023-04-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
by: V. V. Kukharchuk, et al.
Published: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
by: Lijun Wang, et al.
Published: (2018-06-01)

Safety and vasopressor effect of rosuvastatin in septic patients
by: Hanaa A. El Gendy, et al.
Published: (2014-07-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018-10-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020-11-01)

New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life
by: M. V. Ezhov, et al.
Published: (2018-04-01)

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
by: Keiki Sakurama, et al.
Published: (2023-04-01)

Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia
by: M Yu Zubareva, et al.
Published: (2014-06-01)

Investigation of montelukast effect on rosuvastatin induced late puberty in rats
by: Tamadir Hamid Wadi Aledani, et al.
Published: (2022-01-01)

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
by: Tao Yuan, et al.
Published: (2023-04-01)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
by: Marina G. Bubnova, et al.
Published: (2021-06-01)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe from Pharmaceuticals and Biological Samples
by: Sevinç KURBANOĞLU, et al.
Published: (2020-10-01)

Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis—design, rationale, and methodology of the METEOR-China study
by: Yilong Wang, et al.
Published: (2020-11-01)